FF:10600-108E6: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{f5samples | {{f5samples | ||
| | |F5samples= | ||
| | |ancestors_in_anatomy_facet=UBERON:0000014,UBERON:0000061,UBERON:0000062,UBERON:0000064,UBERON:0000465,UBERON:0000467,UBERON:0000468,UBERON:0000475,UBERON:0000479,UBERON:0000480,UBERON:0001062,UBERON:0002097,UBERON:0002199,UBERON:0002384,UBERON:0002416,UBERON:0003102 | ||
|ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000004,CL:0000012,CL:0000034,CL:0000048,CL:0000055,CL:0000057,CL:0000063,CL:0000134,CL:0000144,CL:0000219,CL:0000255,CL:0000548,CL:0000723,CL:0002320,CL:0002371 | |ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000004,CL:0000012,CL:0000034,CL:0000048,CL:0000055,CL:0000057,CL:0000063,CL:0000134,CL:0000144,CL:0000219,CL:0000255,CL:0000548,CL:0000723,CL:0002320,CL:0002371 | ||
|ancestors_in_disease_facet=DOID:0050686,DOID:0050687,DOID:0060100,DOID:1115,DOID:14566,DOID:162,DOID:1907,DOID:201,DOID:4,DOID:4231 | |ancestors_in_disease_facet=DOID:0050686,DOID:0050687,DOID:0060100,DOID:1115,DOID:14566,DOID:162,DOID:1907,DOID:201,DOID:4,DOID:4231 | ||
| | |comment= | ||
|created_by= | |||
|creation_date= | |||
|def= | |||
|fonse_cell_line=FF:0100400,FF:0100453 | |fonse_cell_line=FF:0100400,FF:0100453 | ||
|fonse_cell_line_closure=FF:0100400,FF:0100453 | |fonse_cell_line_closure=FF:0100400,FF:0100453 | ||
Line 66: | Line 34: | ||
|fonse_treatment= | |fonse_treatment= | ||
|fonse_treatment_closure= | |fonse_treatment_closure= | ||
|has_quality= | |has_quality= | ||
|id=FF:10600-108E6 | |||
|is_a=CL:0002620;;DOID:1907;;EFO:0002091;;FF:0000003;;FF:0000210;;FF:0100460 | |is_a=CL:0002620;;DOID:1907;;EFO:0002091;;FF:0000003;;FF:0000210;;FF:0100460 | ||
|name=myxofibrosarcoma cell line:MFH-ino | |||
|namespace=FANTOM5 | |namespace=FANTOM5 | ||
|part_of= | |part_of= | ||
|profile_cagescan=,,, | |||
|profile_hcage=CNhs11729,LSID819,release009,COMPLETED | |||
|profile_rnaseq=,,, | |||
|profile_srnaseq=,,, | |||
|rna_box=108 | |||
|rna_catalog_number= | |||
|rna_concentration=0.72369 | |||
|rna_extraction_protocol=OP-RNA-extraction-totalRNA-miRNeasy_Mini-v1.0 | |||
|rna_lot_number= | |||
|rna_od260/230=2.11 | |||
|rna_od260/280=2.14 | |||
|rna_position=E6 | |||
|rna_rin= | |||
|rna_sample_type=total RNA | |||
|rna_tube_id=108E6 | |||
|rna_weight_ug=34.01343 | |||
|sample_age=unknown | |||
|sample_cell_catalog=RCB0749 | |||
|sample_cell_line=MFH-ino | |||
|sample_cell_lot= | |||
|sample_cell_type=fibroblast | |||
|sample_collaboration=Yukio Nakamura (RIKEN BRC) | |||
|sample_company=RIKEN Bioresource centre | |||
|sample_description= | |||
|sample_dev_stage= | |||
|sample_disease=myxofibrosarcoma | |||
|sample_donor(cell lot)= | |||
|sample_ethnicity=J | |||
|sample_experimental_condition= | |||
|sample_id=10600 | |||
|sample_note= | |||
|sample_sex=female | |||
|sample_species=Human (Homo sapiens) | |||
|sample_strain= | |||
|sample_tissue=ANATOMICAL SYSTEM | |||
|top_motifs=HOXA9_MEIS1:1.13805049519;TFDP1:1.08349565025;VSX1,2:1.05043299501;GFI1:0.915120739548;NR3C1:0.9057280311;E2F1..5:0.887857579673;STAT5{A,B}:0.877274992858;PPARG:0.871180123358;TEAD1:0.797764593599;PAX3,7:0.761988886589;ADNP_IRX_SIX_ZHX:0.744215423929;PBX1:0.740570106435;FOX{I1,J2}:0.732821019813;ONECUT1,2:0.722795452982;PAX6:0.718015437731;ZNF143:0.696228547775;ZNF384:0.682946144759;POU1F1:0.635643451646;POU3F1..4:0.604168440162;HMGA1,2:0.576823776311;GLI1..3:0.573780286151;POU5F1:0.56234782179;AIRE:0.520380582754;NFY{A,B,C}:0.519178122901;LEF1_TCF7_TCF7L1,2:0.501757927488;HOX{A5,B5}:0.49956643703;SOX17:0.483566999182;TAL1_TCF{3,4,12}:0.478770819126;MYB:0.466418269187;GATA4:0.443430831695;FOXD3:0.429888020222;NKX2-3_NKX2-5:0.424433593545;EN1,2:0.418035442352;HMX1:0.405583154039;MZF1:0.397800615422;SRF:0.390460340065;LHX3,4:0.388375191409;ZNF148:0.359631491863;PAX8:0.350905613036;GTF2A1,2:0.340007969752;PITX1..3:0.338558069933;RORA:0.333848212987;NKX6-1,2:0.314944109462;BREu{core}:0.310308130001;FOS_FOS{B,L1}_JUN{B,D}:0.306478539732;IKZF2:0.291483465475;MAZ:0.287161580799;TFAP2B:0.285504865816;EGR1..3:0.259600925206;MED-1{core}:0.240018878915;FOXA2:0.223989099921;OCT4_SOX2{dimer}:0.219530444073;GTF2I:0.211888979073;NRF1:0.211169471223;HOX{A4,D4}:0.199031084444;CUX2:0.197884589731;GFI1B:0.185014346387;ELK1,4_GABP{A,B1}:0.170697613958;PRDM1:0.156907850206;NFATC1..3:0.156206968742;POU6F1:0.137249750734;BACH2:0.136296821041;NANOG:0.133545697362;GCM1,2:0.131564684814;AHR_ARNT_ARNT2:0.119093599893;NFE2:0.114716699055;SOX5:0.111132039438;MAFB:0.108851142085;PAX1,9:0.100223527273;POU2F1..3:0.0997615777777;NR6A1:0.0887382293025;TLX1..3_NFIC{dimer}:0.0846955207243;HLF:0.080371073168;PRRX1,2:0.0551385292427;ZBTB16:0.0509906078151;CRX:0.0490769701155;TFAP4:0.0437859384286;FOSL2:0.0248533074365;NFE2L1:0.024571046635;FOXQ1:0.0240884349836;SOX{8,9,10}:0.0223270709647;HSF1,2:0.0204414784146;ZFP161:0.0199805071182;bHLH_family:0.0194865484358;HIC1:0.0193684737431;GZF1:-0.00221449699342;GATA6:-0.0287203640972;TP53:-0.033071224261;DBP:-0.0331147206143;SP1:-0.0437081992571;CEBPA,B_DDIT3:-0.050723324408;MYBL2:-0.0536834897172;MTF1:-0.0709687307452;FOXO1,3,4:-0.071810892101;SPZ1:-0.0934595635508;HNF1A:-0.097618496925;NFE2L2:-0.0993585835902;TFAP2{A,C}:-0.100535597549;ZBTB6:-0.104665645895;EVI1:-0.113851137083;RBPJ:-0.11452826119;IRF1,2:-0.123999862875;ALX4:-0.12495480966;IRF7:-0.130359372907;KLF4:-0.134016172059;EP300:-0.146825619249;RFX1:-0.156322984028;STAT1,3:-0.163004155383;MEF2{A,B,C,D}:-0.170143985398;BPTF:-0.171464672495;RFX2..5_RFXANK_RFXAP:-0.180630598947;FOXM1:-0.186089624544;YY1:-0.188794591023;ATF2:-0.197969168039;FOX{D1,D2}:-0.213584840653;HNF4A_NR2F1,2:-0.217143721992;TEF:-0.222843408554;AR:-0.223366468236;RXRA_VDR{dimer}:-0.232289124872;MYFfamily:-0.23304696083;ALX1:-0.236640269995;HBP1_HMGB_SSRP1_UBTF:-0.239171054144;NR1H4:-0.252161050725;XBP1:-0.257534831197;PAX5:-0.273997068906;ARID5B:-0.280742517553;PAX2:-0.280873620884;ZIC1..3:-0.285330856984;MTE{core}:-0.286565043765;UFEwm:-0.288349904111;NKX3-1:-0.300832574018;FOXP1:-0.310550039272;DMAP1_NCOR{1,2}_SMARC:-0.314338081704;CREB1:-0.325892007987;FOX{F1,F2,J1}:-0.328022572845;XCPE1{core}:-0.328721241313;ATF5_CREB3:-0.351082667607;NFIX:-0.358119374589;NANOG{mouse}:-0.364804104927;REST:-0.367847728265;EBF1:-0.367999545443;CDX1,2,4:-0.371432636141;STAT2,4,6:-0.378209763298;NFKB1_REL_RELA:-0.393753569646;NKX3-2:-0.40887298605;FOXL1:-0.412704418202;NHLH1,2:-0.425484716495;TBX4,5:-0.431448547197;ATF4:-0.43322058768;NKX2-2,8:-0.433319848896;SPIB:-0.436871533307;RUNX1..3:-0.440427705418;IKZF1:-0.442068321598;TFCP2:-0.444784471423;SNAI1..3:-0.448310288609;RXR{A,B,G}:-0.463608590718;ESR1:-0.479994528905;PATZ1:-0.4891236538;PDX1:-0.490557544661;RREB1:-0.4961823607;PAX4:-0.526383344109;SOX2:-0.536705831249;ESRRA:-0.549327635587;HES1:-0.565538064025;ELF1,2,4:-0.579960871259;RXR{A,B,G}_{NR1H2,PPAR}dimers:-0.583748002882;SPI1:-0.603493579606;NR5A1,2:-0.607854950595;TOPORS:-0.608649639745;ZNF238:-0.611761223569;ETS1,2:-0.614396556724;LMO2:-0.616685277712;HOX{A6,A7,B6,B7}:-0.621799013848;NFIL3:-0.629982957007;SREBF1,2:-0.647842304671;JUN:-0.660048726453;CDC5L:-0.683209316185;ZEB1:-0.725128401023;FOXP3:-0.741752769838;ZNF423:-0.75832170092;TBP:-0.759583487336;MYOD1:-0.781581108895;NKX2-1,4:-0.821866251039;TGIF1:-0.837233765787;HAND1,2:-0.870553574004;FOXN1:-0.892965559435;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:-1.05379827979;SMAD1..7,9:-1.21866212585;TLX2:-1.40554917555;T:-1.52149841351;HIF1A:-1.59232263004;ATF6:-1.60132946547 | |||
}} | }} |
Revision as of 14:10, 21 March 2012
Name: | myxofibrosarcoma cell line:MFH-ino |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11729
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11729
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.883 |
10 | 10 | 0.296 |
100 | 100 | 0.96 |
101 | 101 | 0.362 |
102 | 102 | 0.317 |
103 | 103 | 0.458 |
104 | 104 | 0.967 |
105 | 105 | 0.51 |
106 | 106 | 0.0567 |
107 | 107 | 0.318 |
108 | 108 | 0.371 |
109 | 109 | 0.184 |
11 | 11 | 0.176 |
110 | 110 | 0.386 |
111 | 111 | 0.945 |
112 | 112 | 0.218 |
113 | 113 | 0.324 |
114 | 114 | 0.395 |
115 | 115 | 0.436 |
116 | 116 | 0.871 |
117 | 117 | 0.235 |
118 | 118 | 0.574 |
119 | 119 | 0.442 |
12 | 12 | 0.0439 |
120 | 120 | 0.104 |
121 | 121 | 0.939 |
122 | 122 | 0.582 |
123 | 123 | 0.243 |
124 | 124 | 0.687 |
125 | 125 | 0.244 |
126 | 126 | 0.154 |
127 | 127 | 0.425 |
128 | 128 | 0.277 |
129 | 129 | 0.71 |
13 | 13 | 0.212 |
130 | 130 | 0.084 |
131 | 131 | 0.523 |
132 | 132 | 0.487 |
133 | 133 | 0.841 |
134 | 134 | 0.95 |
135 | 135 | 0.0203 |
136 | 136 | 0.837 |
137 | 137 | 0.147 |
138 | 138 | 0.797 |
139 | 139 | 0.0132 |
14 | 14 | 0.323 |
140 | 140 | 0.211 |
141 | 141 | 0.344 |
142 | 142 | 0.302 |
143 | 143 | 0.463 |
144 | 144 | 0.316 |
145 | 145 | 0.804 |
146 | 146 | 0.314 |
147 | 147 | 0.4 |
148 | 148 | 0.00808 |
149 | 149 | 0.0252 |
15 | 15 | 0.983 |
150 | 150 | 0.559 |
151 | 151 | 0.353 |
152 | 152 | 0.408 |
153 | 153 | 0.159 |
154 | 154 | 0.494 |
155 | 155 | 0.0854 |
156 | 156 | 0.687 |
157 | 157 | 0.677 |
158 | 158 | 0.0832 |
159 | 159 | 0.618 |
16 | 16 | 0.653 |
160 | 160 | 0.947 |
161 | 161 | 0.206 |
162 | 162 | 0.598 |
163 | 163 | 0.556 |
164 | 164 | 0.47 |
165 | 165 | 0.845 |
166 | 166 | 0.713 |
167 | 167 | 0.884 |
168 | 168 | 0.377 |
169 | 169 | 0.318 |
17 | 17 | 0.579 |
18 | 18 | 0.742 |
19 | 19 | 0.246 |
2 | 2 | 0.207 |
20 | 20 | 0.824 |
21 | 21 | 0.637 |
22 | 22 | 0.741 |
23 | 23 | 0.281 |
24 | 24 | 0.135 |
25 | 25 | 0.975 |
26 | 26 | 0.891 |
27 | 27 | 0.356 |
28 | 28 | 0.972 |
29 | 29 | 0.33 |
3 | 3 | 0.0877 |
30 | 30 | 0.324 |
31 | 31 | 0.219 |
32 | 32 | 0.328 |
33 | 33 | 0.201 |
34 | 34 | 0.152 |
35 | 35 | 0.173 |
36 | 36 | 0.172 |
37 | 37 | 0.344 |
38 | 38 | 0.481 |
39 | 39 | 0.33 |
4 | 4 | 0.341 |
40 | 40 | 0.262 |
41 | 41 | 0.534 |
42 | 42 | 0.717 |
43 | 43 | 0.235 |
44 | 44 | 0.015 |
45 | 45 | 0.882 |
46 | 46 | 0.908 |
47 | 47 | 0.408 |
48 | 48 | 0.242 |
49 | 49 | 0.862 |
5 | 5 | 0.817 |
50 | 50 | 0.563 |
51 | 51 | 0.947 |
52 | 52 | 0.694 |
53 | 53 | 0.52 |
54 | 54 | 0.376 |
55 | 55 | 0.926 |
56 | 56 | 0.872 |
57 | 57 | 0.242 |
58 | 58 | 0.471 |
59 | 59 | 0.0811 |
6 | 6 | 0.405 |
60 | 60 | 0.16 |
61 | 61 | 0.523 |
62 | 62 | 0.866 |
63 | 63 | 0.129 |
64 | 64 | 0.556 |
65 | 65 | 0.18 |
66 | 66 | 0.00111 |
67 | 67 | 0.961 |
68 | 68 | 0.195 |
69 | 69 | 0.98 |
7 | 7 | 0.359 |
70 | 70 | 0.0203 |
71 | 71 | 0.283 |
72 | 72 | 0.238 |
73 | 73 | 0.394 |
74 | 74 | 0.475 |
75 | 75 | 0.17 |
76 | 76 | 0.377 |
77 | 77 | 0.0681 |
78 | 78 | 0.598 |
79 | 79 | 0.00389 |
8 | 8 | 0.944 |
80 | 80 | 0.961 |
81 | 81 | 0.924 |
82 | 82 | 0.0314 |
83 | 83 | 0.233 |
84 | 84 | 0.0046 |
85 | 85 | 0.00386 |
86 | 86 | 0.112 |
87 | 87 | 0.713 |
88 | 88 | 0.357 |
89 | 89 | 0.714 |
9 | 9 | 0.943 |
90 | 90 | 0.87 |
91 | 91 | 0.0266 |
92 | 92 | 0.236 |
93 | 93 | 0.726 |
94 | 94 | 0.875 |
95 | 95 | 0.333 |
96 | 96 | 0.459 |
97 | 97 | 0.126 |
98 | 98 | 0.046 |
99 | 99 | 0.425 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs11729
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
CL:0002620 skin fibroblast
DOID:1907 malignant fibroxanthoma
EFO:0002091 biological replicate
FF:0000003 cell line sample
FF:0000210 human sample
FF:0100460 fibrosarcoma cell line sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000034 (stem cell)
0000048 (multi fate stem cell)
0000055 (non-terminally differentiated cell)
0000057 (fibroblast)
0000134 (mesenchymal cell)
0000219 (motile cell)
0000255 (eukaryotic cell)
0000548 (animal cell)
0000723 (somatic stem cell)
0002320 (connective tissue cell)
0002371 (somatic cell)
DOID: Disease
0050686 (organ system cancer)
0050687 (cell type cancer)
0060100 (musculoskeletal system cancer)
1115 (sarcoma)
14566 (disease of cellular proliferation)
162 (cancer)
1907 (malignant fibroxanthoma)
201 (connective tissue cancer)
4 (disease)
4231 (histiocytoma)
UBERON: Anatomy
0000014 (zone of skin)
0000061 (anatomical structure)
0000062 (organ)
0000064 (organ part)
0000465 (material anatomical entity)
0000467 (anatomical system)
0000468 (multi-cellular organism)
0000475 (organism subdivision)
0000479 (tissue)
0000480 (anatomical group)
0001062 (anatomical entity)
0002097 (skin of body)
0002199 (integument)
0002384 (connective tissue)
0002416 (integumental system)
0003102 (surface structure)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA